DT
Healthcare & Life Sciences
Diamond Therapeutics
Diamond Therapeutics is a Healthcare & Life Sciences startup, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Diamond Therapeutics
Diamond Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Diamond Therapeutics is developing sub-perceptual, non-hallucinogenic treatments based on psychedelic compounds aimed at addressing a broad range of mental health conditions.
Explore Diamond Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.